ইস্রায়েল - হিব্রু - Ministry of Health

abbott medical laboratories ltd, israel - dydrogesterone - טבליות מצופות פילם - dydrogesterone 10 mg - dydrogesterone - dydrogesterone - cases where progesterone supplement is needed.

ইস্রায়েল - হিব্রু - Ministry of Health

bayer israel ltd - estradiol valerate; estradiol valerate; norgestrel - טבליה - estradiol valerate 2 mg; norgestrel 0.5 mg; estradiol valerate 2 mg - norgestrel and estrogen - norgestrel and estrogen - two phase preparation for climacteric and cycle disturbances.

ইস্রায়েল - হিব্রু - Ministry of Health

merck serono ltd - follitropin alfa; lutropin alfa - אבקה וממס להכנת תמיסה להזרקה - follitropin alfa 150 iu; lutropin alfa 75 iu - follitropin alfa - follitropin alfa - pergoveris is indicated for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials, these patients were defined by an endogenous serum lh level < 1.2 iu/l.

ইস্রায়েল - হিব্রু - Ministry of Health

j-c health care ltd - oxybutynin chloride - טבליות בשחרור ממושך - oxybutynin chloride 5 mg - oxybutynin - oxybutynin - once daily controlled-release tablet indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.

ইস্রায়েল - হিব্রু - Ministry of Health

j-c health care ltd - oxybutynin chloride - טבליות בשחרור ממושך - oxybutynin chloride 10 mg - oxybutynin - oxybutynin - once daily controlled-release tablet indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.

ইস্রায়েল - হিব্রু - Ministry of Health

cts ltd - solifenacin succinate - טבליות מצופות פילם - solifenacin succinate 5 mg - solifenacin - solifenacin - vesicare is indicated for symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.

ইস্রায়েল - হিব্রু - Ministry of Health

cts ltd - solifenacin succinate - טבליות מצופות פילם - solifenacin succinate 10 mg - solifenacin - solifenacin - vesicare is indicated for symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.

ইস্রায়েল - হিব্রু - Ministry of Health

pfizer pharmaceuticals israel ltd - pegvisomant - אבקה וממס להכנת תמיסה להזרקה - pegvisomant 10 mg - pegvisomant - pegvisomant - treatment of patient with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalize igf-i concentrations or was not tolerated.

ইস্রায়েল - হিব্রু - Ministry of Health

pfizer pharmaceuticals israel ltd - pegvisomant - אבקה וממס להכנת תמיסה להזרקה - pegvisomant 15 mg - pegvisomant - pegvisomant - treatment of patient with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not narmalize igf-i concentrations or was not tolerated.

ইস্রায়েল - হিব্রু - Ministry of Health

pfizer pharmaceuticals israel ltd - pegvisomant - אבקה וממס להכנת תמיסה להזרקה - pegvisomant 20 mg - pegvisomant - pegvisomant - treatment of patient with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not narmalize igf-i concentrations or was not tolerated.